Literature DB >> 2229431

Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours.

P A van Dam1, J V Watson, D G Lowe, H Cox, M Curling, J H Shepherd.   

Abstract

A multiparameter flow cytometric assay for the simultaneous study of tumour associated antigens (TAA) and DNA in fresh solid tumours was devised. Cell suspensions were prepared by disaggregating unfixed solid tumour samples mechanically over a stainless steel mesh. Indirect immunofluorescence was used to identify the TAA, and DNA was stained with propidium iodide. Cell morphology was well preserved, cell clumping was negligible, and high quality indirect immunofluorescence quality indirect immunofluorescence and DNA staining were obtained. The technique is simple, rapid, and reproducible. Multiparameter assays can be developed to study prognostic indicators such as membrane oncoproteins, receptors, and multidrug resistance in solid tumours. With a suitable panel of antibodies the technique might become an aid in the differential diagnosis and biochemical diagnosis of some solid tumours.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229431      PMCID: PMC502834          DOI: 10.1136/jcp.43.10.833

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  Limitations in the measurement of c-myc oncoprotein and other nuclear antigens by flow cytometry.

Authors:  S T Lincoln; K D Bauer
Journal:  Cytometry       Date:  1989-07

2.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

3.  A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.

Authors:  S Nozawa; M Sakayori; K Ohta; R Iizuka; H Mochizuki; M Soma; J Fujimoto; J Hata; M Iwamori; Y Nagai
Journal:  Am J Obstet Gynecol       Date:  1989-10       Impact factor: 8.661

4.  Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.

Authors:  K Sasaki; M Nagai; H Kato; T Torigoe; Y Nagamine; M Takahashi
Journal:  Gan       Date:  1984-08

5.  Expression of Ca antigen in relation to cell cycle in cultured human tumor cells.

Authors:  B Czerniak; Z Darzynkiewicz; L Staiano-Coico; F Herz; L G Koss
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Sensitive three-parameter flow-cytometric detection of abnormal cells in human cervical cancers: a pilot study.

Authors:  G Valet; M G Ormerod; H H Warnecke; G Benker; G Ruhenstroth-Bauer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

7.  Comparative flow DNA analysis of different cell suspensions in breast carcinoma.

Authors:  A Chassevent; A Daver; G Bertrand; H Coic; J Geslin; M C Bidabe; P George; F Larra
Journal:  Cytometry       Date:  1984-05

8.  Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma, and lung tumors.

Authors:  H K Slocum; Z P Pavelic; Y M Rustum; P J Creaven; C Karakousis; H Takita; W R Greco
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

9.  Automated flow-cytometric identification of colo-rectal tumour cells by simultaneous DNA, CEA-antibody and cell volume measurements.

Authors:  G Valet; L Rüssmann; R Wirsching
Journal:  J Clin Chem Clin Biochem       Date:  1984-12

10.  A method for improving light collection by 600% from square cross section flow cytometry chambers.

Authors:  J V Watson
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

View more
  4 in total

1.  Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.

Authors:  P A van Dam; I B Vergote; D G Lowe; J V Watson; P van Damme; J C van der Auwera; J H Shepherd
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

2.  Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue.

Authors:  M R Buist; C F Molthoff; P Kenemans; C J Meijer
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

3.  Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Authors:  Cristiane S Ferreira-Facio; Cristiane Milito; Vitor Botafogo; Marcela Fontana; Leandro S Thiago; Elen Oliveira; Ariovaldo S da Rocha-Filho; Fernando Werneck; Danielle N Forny; Samuel Dekermacher; Ana Paula de Azambuja; Sima Esther Ferman; Paulo Antônio Silvestre de Faria; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

4.  Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer Treatment.

Authors:  Ahmed A Markeb; Nagwa A El-Maali; Douaa M Sayed; Amany Osama; Mohamed A Y Abdel-Malek; Amen H Zaki; Mostafa E A Elwanis; James J Driscoll
Journal:  Int J Breast Cancer       Date:  2016-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.